Journal
FRONTIERS IN SURGERY
Volume 9, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fsurg.2022.982114
Keywords
transcatheter arterial chemoembolization; elderly; hepatocellular carcinoma; lactate dehydrogenase; long-term prognosis
Categories
Ask authors/readers for more resources
Hepatic arterial chemoembolization is effective for treating HCC and improving survival rates, but long-term prognosis remains unfavorable for patients. Serum LDH has potential as an indicator for predicting tumor proliferation and progression, but its relationship with HCC prognosis is still unclear.
Hepatic arterial chemoembolization is an effective treatment for primary hepatocellular carcinoma (HCC) and can improve the survival rate of patients. Nevertheless, the long-term prognosis of patients with HCC is not optimistic. In recent years, tumor humoral detection has attracted extensive attention and is expected to become the main examination method for early tumor screening. Studies have found that serum LDH is an indicator with effective potential to predict tumor proliferation and progression, such as pancreatic cancer, esophageal cancer, nasopharyngeal cancer, etc., but the relationship between this indicator and the prognosis of HCC is still unclear. The purpose of this study was to clarify the relationship between serum LDH and the prognosis of patients with HCC, so as to provide an important scientific basis for prognosis judgment of HCC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available